pRb controls estrogen receptor alpha protein stability and activity

Isabella Caligiuri, Giuseppe Toffoli, Antonio Giordano, Flavio Rizzolio

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A cross talk between the Estrogen Receptor (ESR1) and the Retinoblastoma (pRb) pathway has been demonstrated to influence the therapeutic response of breast cancer patients but the full mechanism remains poorly understood. Here we show that the N-terminal domain of pRb interacts with the CD domain of ESR1 to allow for the assembly of intermediate complex chaperone proteins HSP90 and p23. We demonstrated that a loss of pRb in human/mouse breast cells decreases the expression of the ESR1 protein through the proteasome pathway. Our work reveals a novel regulatory mechanism of ESR1 basal turnover and activity and an unanticipated relationship with the pRb tumor suppressor.

Original languageEnglish
Pages (from-to)875-883
Number of pages9
JournalOncotarget
Volume4
Issue number6
Publication statusPublished - Jun 2013

Fingerprint

Retinoblastoma
Estrogen Receptor alpha
Protein Stability
Proteasome Endopeptidase Complex
Estrogen Receptors
Breast
Breast Neoplasms
Neoplasms
Proteins
Therapeutics
protein p23
estrophilin

Keywords

  • Breast cancer
  • Chaperone proteins
  • Estrogen receptor alpha
  • Prb
  • Proteasome

ASJC Scopus subject areas

  • Oncology

Cite this

Caligiuri, I., Toffoli, G., Giordano, A., & Rizzolio, F. (2013). pRb controls estrogen receptor alpha protein stability and activity. Oncotarget, 4(6), 875-883.

pRb controls estrogen receptor alpha protein stability and activity. / Caligiuri, Isabella; Toffoli, Giuseppe; Giordano, Antonio; Rizzolio, Flavio.

In: Oncotarget, Vol. 4, No. 6, 06.2013, p. 875-883.

Research output: Contribution to journalArticle

Caligiuri, I, Toffoli, G, Giordano, A & Rizzolio, F 2013, 'pRb controls estrogen receptor alpha protein stability and activity', Oncotarget, vol. 4, no. 6, pp. 875-883.
Caligiuri I, Toffoli G, Giordano A, Rizzolio F. pRb controls estrogen receptor alpha protein stability and activity. Oncotarget. 2013 Jun;4(6):875-883.
Caligiuri, Isabella ; Toffoli, Giuseppe ; Giordano, Antonio ; Rizzolio, Flavio. / pRb controls estrogen receptor alpha protein stability and activity. In: Oncotarget. 2013 ; Vol. 4, No. 6. pp. 875-883.
@article{a1d8484ba4524edaa4ee84612eb2cbbc,
title = "pRb controls estrogen receptor alpha protein stability and activity",
abstract = "A cross talk between the Estrogen Receptor (ESR1) and the Retinoblastoma (pRb) pathway has been demonstrated to influence the therapeutic response of breast cancer patients but the full mechanism remains poorly understood. Here we show that the N-terminal domain of pRb interacts with the CD domain of ESR1 to allow for the assembly of intermediate complex chaperone proteins HSP90 and p23. We demonstrated that a loss of pRb in human/mouse breast cells decreases the expression of the ESR1 protein through the proteasome pathway. Our work reveals a novel regulatory mechanism of ESR1 basal turnover and activity and an unanticipated relationship with the pRb tumor suppressor.",
keywords = "Breast cancer, Chaperone proteins, Estrogen receptor alpha, Prb, Proteasome",
author = "Isabella Caligiuri and Giuseppe Toffoli and Antonio Giordano and Flavio Rizzolio",
year = "2013",
month = "6",
language = "English",
volume = "4",
pages = "875--883",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "6",

}

TY - JOUR

T1 - pRb controls estrogen receptor alpha protein stability and activity

AU - Caligiuri, Isabella

AU - Toffoli, Giuseppe

AU - Giordano, Antonio

AU - Rizzolio, Flavio

PY - 2013/6

Y1 - 2013/6

N2 - A cross talk between the Estrogen Receptor (ESR1) and the Retinoblastoma (pRb) pathway has been demonstrated to influence the therapeutic response of breast cancer patients but the full mechanism remains poorly understood. Here we show that the N-terminal domain of pRb interacts with the CD domain of ESR1 to allow for the assembly of intermediate complex chaperone proteins HSP90 and p23. We demonstrated that a loss of pRb in human/mouse breast cells decreases the expression of the ESR1 protein through the proteasome pathway. Our work reveals a novel regulatory mechanism of ESR1 basal turnover and activity and an unanticipated relationship with the pRb tumor suppressor.

AB - A cross talk between the Estrogen Receptor (ESR1) and the Retinoblastoma (pRb) pathway has been demonstrated to influence the therapeutic response of breast cancer patients but the full mechanism remains poorly understood. Here we show that the N-terminal domain of pRb interacts with the CD domain of ESR1 to allow for the assembly of intermediate complex chaperone proteins HSP90 and p23. We demonstrated that a loss of pRb in human/mouse breast cells decreases the expression of the ESR1 protein through the proteasome pathway. Our work reveals a novel regulatory mechanism of ESR1 basal turnover and activity and an unanticipated relationship with the pRb tumor suppressor.

KW - Breast cancer

KW - Chaperone proteins

KW - Estrogen receptor alpha

KW - Prb

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=84880845947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880845947&partnerID=8YFLogxK

M3 - Article

C2 - 23900261

AN - SCOPUS:84880845947

VL - 4

SP - 875

EP - 883

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 6

ER -